Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
Recruiting now
Conditions studied: Hepatic Encephalopathy
In brief
assess the correlation between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease. assess the impact of albumin level on clinical course and outcomes of HE.
Key facts
- Study ID
- NCT06953921
- Run by
- Sohag University
- People needed
- 100
- Starts
- 2025-03-12
- Expected to finish
- 2025-09-12
- Last updated by the study team
- 2025-05-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients aged >18 years.
- Confirmed chronic liver disease (by imaging ,
- liver function tests , and clinical history).
- Diagnosed with hepatic encephalopathy based on clinical criteria.
- Patients able to provide informed consent.
You may not qualify if…
- Patients age less than 18 years old
- Acute liver failure.
- Chronic renal failure on dialysis.
- Pregnant women.
- Patients with active malignancy.
Where it is running
- Sohag university hospital — Sohag, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.